Leiutis Pharmaceuticals

Leiutis Pharmaceuticals is a specialty pharmaceutical product innovation company based in Hyderabad, India, specializing in specialty nanotherapeutics and novel drug delivery systems. The company focuses on developing next-generation medicines with improved pharmacology and product profiles across therapeutic areas such as neuropsychiatry, pain management, oncology, and hormonal disorders. Leiutis utilizes its proprietary nanodispersible drug delivery platform to enhance the absorption and efficacy of complex therapeutics. In July 2026, the company achieved a major milestone with the CDSCO approval of its proprietary Synthetic Cannabidiol Oral Solution (150 mg/mL) for mild to moderate anxiety disorders, developed in collaboration with Biophore India Pharmaceuticals and Zenara Pharma. Leiutis operates on a collaborative business model, partnering with major pharmaceutical companies and CDMOs like Akums Drugs & Pharmaceuticals to manufacture and commercialize its innovative pipeline globally.